Allogeneic haematopoietic cell transplantation (allo-HCT) remains the only curative
approach in myelofibrosis (MF). Despite advances over recent decades, relapse and non …

This review highlights literature pertinent to chimerism analysis in the context of
hematopoietic cell transplantation (HCT). We also conducted a survey of testing practices of …

The number of patients with myelofibrosis (MF) undergoing an allogeneic hemopoietic stem
cell transplantation (HSCT) is increasing: in the analysis of the European Group for Blood …

Dear Editor, Myelofibrosis (MF) is the most severe form of myeloproliferative neoplasm
(MPN). Allogeneic hematopoietic stem cell transplantation (allo-HCT) is the only known …

Myelofibrosis (MF) is a clonal myeloproliferative neoplasm characterized by inflammation,
marrow fibrosis, and an inherent risk of blastic transformation. Hematopoietic allogeneic …

The aim of this retrospective study was to assess the rate of full donor chimerism (F‐DC) in
patients with myelofibrosis, prepared for an allogeneic stem cell transplant, with one or two …

Factors predicting allogeneic hematopoietic cell transplantation (HCT) outcomes in
myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to …

We investigated risk factors for the development of mixed chimerism in 131 patients who
underwent transplantation for myelofibrosis and determined the impact of lymphoid (CD3+) …

Myelofibrosis is a devastating myeloid malignancy characterized by dysregulation of the JAK-
STAT pathway, resulting in splenomegaly, constitutional symptoms, anemia …

Fanconi anemia (FA) cells are characterized by genomic instability, which places FA
patients at risk for malignancies such as leukemia and oropharyngeal/urogenital cancers …